Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina

Therapy delivery methods aren’t always the focus when we discuss gene therapy strategies. However, they play such a critical role in the holistic success of a gene therapy. A valid gene therapy strategy which stems from years of challenging, good scientific work can sometimes be tainted or unproven because of a poorly designed delivery system or human error at the time of a procedure. Researchers at John Hopkins are working on a delivery concept that could be as affective as sub-retinal injections, but much safer. READ MORE